.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,119,080

« Back to Dashboard

Claims for Patent: 7,119,080

Title:Boronic ester and acid compounds, synthesis and uses
Abstract:Disclosed herein is a method for reducing the rate of degradation of proteins in an animal, comprising contacting cells of the animal with certain boronic ester and acid compounds. Also disclosed herein are novel boronic ester and acid compounds, their synthesis and uses.
Inventor(s): Adams; Julian (Chestnut Hill, MA), Ma; Yu-Ting (Needham, MA), Stein; Ross L. (Sudbury, MA), Baevsky; Matthew (Grafton, MA), Grenier; Louis (Medford, MA), Plamondon; Louis (Belmont, MA)
Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:10/730,231
Patent Claims: 1. A compound having the formula (1a): ##STR00052## or a pharmaceutically acceptable salt thereof; wherein P is hydrogen or an amino group protecting moiety; A is zero; X.sup.2 is --C(O)--NH--; R is hydrogen or C.sub.1-8 alkyl; R.sup.2 is --CH.sub.2--R.sup.5; R.sup.3 is C.sub.4 alkyl; R.sup.5 is aryl or cycloalkyl, wherein R.sup.5 is optionally substituted by one or two substituents independently selected from the group consisting of C.sub.1-6 alkyl, C.sub.3-8 cycloalkyl, C.sub.1-6alkyl(C.sub.3-8)cycloalkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, cyano, amino, C.sub.1-6 alkylamino, di(C.sub.1-6)alkylamino, benzylamino, dibenzylamino, nitro, carboxy, carbo(C.sub.1-6)alkoxy, trifluoromethyl, halogen, C.sub.1-6 alkoxy, C.sub.6-10 aryl, C.sub.6-10 aryl(C.sub.1-6)alkyl, C.sub.6-10 aryl(C.sub.1-6)alkoxy, hydroxy, C.sub.1-6 alkylthio, C.sub.1-6 alkylsulfinyl, C.sub.1-6 alkylsulfonyl, C.sub.6-10 arylthio, C.sub.6-10 arylsulfinyl, C.sub.6-10 arylsulfonyl, C.sub.1-6 alkyl(C.sub.6-10)aryl, and halo(C.sub.6-10)aryl; Z.sup.1 and Z.sup.2 are each independently one of alkyl, hydroxy, alkoxy, or aryloxy, or together Z.sup.1 and Z.sup.2 form a moiety derived from a dihydroxy compound having at least two hydroxy groups separated by at least two connecting atoms in a chain or ring, said chain or ring comprising carbon atoms and, optionally, a heteroatom or heteroatoms which can be N, S, or O.

2. The compound of claim 1, wherein R is hydrogen.

3. The compound of claim 1, wherein R.sup.3 is isobutyl.

4. The compound of claim 1, wherein P is R.sup.7--C(O)-- or R.sup.7--SO.sub.2--, where R.sup.7 is one of alkyl, cycloalkyl, aryl, aralkyl, heteroaryl, heteroarylalkyl, or a saturated or partially unsaturated heterocycle, wherein the ring portion of R.sup.7 is optionally substituted.

5. The compound of claim 1, wherein P is R.sup.7--NH--C(O)-- or R.sup.7--O--C(O)--, where R.sup.7 is one of alkyl, cycloalkyl, aryl, aralkyl, heteroaryl, or heteroarylalkyl, wherein the ring portion of R.sup.7 is optionally substituted.

6. The compound of claim 4 or 5, wherein R.sup.7 is an optionally substituted aryl or aralkyl.

7. The compound of claim 4 or 5, wherein R.sup.7 is an optionally substituted heteroaryl or heteroaralkyl.

8. The compound of claim 1, wherein R.sup.5 is an optionally substituted C.sub.6-10 aryl.

9. The compound of claim 1, wherein R.sup.5 is phenyl.

10. The compound of claim 9, wherein Z.sup.1 and Z.sup.2 are both hydroxy.

11. The compound of claim 9, wherein Z.sup.1 and Z.sup.2 together form a moiety derived from a dihydroxy compound having at least two hydroxy groups separated by at least two connecting atoms in a chain or ring, said chain or ring comprising carbon atoms and, optionally a heteroatom or heteroatoms independently selected from the group consisting of N, S, and O.

12. A compound having the formula (1a): ##STR00053## or a pharmaceutically acceptable salt thereof; wherein P is R.sup.7--C(O)-- or R.sup.7--SO.sub.2--, and R.sup.7 is an optionally substituted aryl or aralkyl; A is zero; X.sup.2 is --C(O)--NH--; R is hydrogen; R.sup.2 is benzyl; R.sup.3 is C.sub.4 alkyl; and Z.sup.1 and Z.sup.2 are independently one of hydroxy, alkoxy, or aryloxy, or together Z.sup.1 and Z.sup.2 form a moiety derived from a dihydroxy compound having at least two hydroxy groups separated by at least two connecting atoms in a chain or ring, said chain or ring comprising carbon atoms and, optionally, a heteroatom or heteroatoms which can be N, S, or O.

13. The compound of claim 12, wherein R.sup.7 is phenyl.

14. A composition, which upon combination with a physiologically acceptable saline carrier forms a solution suitable for intravenous, intramuscular or subcutaneous administration to a patient, said solution comprising a compound of the formula (1a): ##STR00054## or a pharmaceutically acceptable salt thereof; wherein P is hydrogen or an amino group protecting moiety; A is zero; X.sup.2 is --C(O)--NH--; R is hydrogen or C.sub.1-8 alkyl; R.sup.2 is --CH.sub.2--R.sup.5; R.sup.3 is C.sub.4 alkyl; R.sup.5 is aryl or cycloalkyl, wherein R.sup.5 is optionally substituted by one or two substituents independently selected from the group consisting of C.sub.1-6 alkyl, C.sub.3-8 cycloalkyl, C.sub.1-6alkyl(C.sub.3-8)cycloalkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, cyano, amino, C.sub.1-6 alkylamino, di(C.sub.1-6)alkylamino, benzylamino, dibenzylamino, nitro, carboxy, carbo(C.sub.1-6)alkoxy, trifluoromethyl, halogen, C.sub.1-6 alkoxy, C.sub.6-10 aryl, C.sub.6-10 aryl(C.sub.1-6)alkyl, C.sub.6-10 aryl(C.sub.1-6)alkoxy, hydroxy, C.sub.1-6 alkylthio, C.sub.1-6 alkylsulfinyl, C.sub.1-6 alkylsulfonyl, C.sub.6-10 arylthio, C.sub.6-10 arylsulfinyl, C.sub.6-10 arylsulfonyl, C.sub.1-6 alkyl(C.sub.6-10)aryl, and halo(C.sub.6-10)aryl; Z.sup.1 and Z.sup.2 are both hydroxy.

15. The composition of claim 14, wherein R is hydrogen.

16. The composition of claim 14, wherein R.sup.3 is isobutyl.

17. The composition of claim 14, wherein P is R.sup.7--C(O)-- or R.sup.7--SO.sub.2--, where R.sup.7 is one of alkyl, cycloalkyl, aryl, aralkyl, heteroaryl, heteroarylalkyl, or a saturated or partially unsaturated heterocycle, wherein the ring portion of R.sup.7 is optionally substituted.

18. The composition of claim 14, wherein P is R.sup.7--NH--C(O)-- or R.sup.7--O--C(O)--, where R.sup.7 is one of alkyl, cycloalkyl, aryl, aralkyl, heteroaryl, or heteroarylalkyl, wherein the ring portion of R.sup.7 is optionally substituted.

19. The composition of claim 17 or 18, wherein R.sup.7 is an optionally substituted aryl or aralkyl.

20. The composition of claim 17 or 18, wherein R.sup.7 is an optionally substituted heteroaryl or heteroaralkyl.

21. The composition of claim 14, wherein R.sup.5 is an optionally substituted C.sub.6-10 aryl.

22. The composition of claim 14, wherein R.sup.5 is phenyl.

23. A composition, which upon combination with a physiologically acceptable saline carrier forms a solution suitable for intravenous, intramuscular or subcutaneous administration to a patient, said solution comprising a compound of the formula (1a): ##STR00055## or a pharmaceutically acceptable salt thereof; wherein P is R.sup.7--C(O)-- or R.sup.7--SO.sub.2--, and R.sup.7 is an optionally substituted aryl or aralkyl; A is zero; X.sup.2 is --C(O)--NH--; R is hydrogen; R.sup.2 is benzyl; R.sup.3 is C.sub.4 alkyl; and Z.sup.1 and Z.sup.2 are both hydroxy.

24. The composition of claim 23, wherein R.sup.7 is phenyl.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc